Case Study: Biotechnology Exporter achieves scalable risk management and revenue certainty with Rochford Capital

A Biotechnology Business, Heavily Focused on R&d for Years, Was Now Experiencing Rapid Sales Growth Without a Robust Policy Framework to Protect Itself Against the Rapidly Growing Risk Profile

Biotechnology Exporter, a rapidly growing biotech business focused on R&D and export sales, needed to strengthen its treasury controls as rising cash flow forecasts increased its exposure to FX and market risk. Rochford Capital was brought in to help develop an appropriate treasury and hedging policy framework, since the finance team and Board lacked direct experience in designing one.

Rochford Capital worked with the CFO and Board to present and approve a hedging policy, then helped the finance team implement an initial hedging strategy to achieve base compliance. Rochford Capital now provides ongoing hedging advice and monthly reporting, using the right product mix to keep the company compliant while improving revenue certainty, reducing risk premium, and supporting a smoother earnings profile that can lower cost of capital and enhance enterprise value.